| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Motilal Oswal BSE Healthcare ETF |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.12 |
| Equity |
99.88 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
36.38% |
| Top 10 Holdings |
55.08% |
| Top 25 Holdings |
77.95% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
75.95 |
| Healthcare |
23.93 |
| Cash |
0.12 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.96 |
| PE Ratio |
38.09 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
13.91 |
| DIVI LABORATORIES LTD |
5.90 |
| Dr Reddys Laboratories Limited |
5.74 |
| Apollo Hospitals Enterprise Limited |
5.55 |
| Cipla Limited |
5.28 |
| Max Healthcare Institute Limited |
5.23 |
| Lupin Limited |
3.97 |
| Fortis Health Care Ltd |
3.43 |
| Laurus Labs Limited |
3.04 |
| Torrent Pharmaceuticals Limited |
3.03 |
| Aurobindo Pharma Limited |
2.76 |
| Glenmark Pharmaceuticals Limited |
2.56 |
| Alkem Laboratories Limited |
2.25 |
| Biocon Limited |
1.87 |
| Mankind Pharma Limited |
1.78 |
| Zydus Lifesciences Limited |
1.60 |
| IPCA Laboratories Limited |
1.52 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
1.32 |
| J B Chemicals and Pharma Ltd |
1.22 |
| Krishna Inst of Medical Sciences Ltd. |
1.18 |
| Sai Life Sciences Limited |
1.03 |
| Gland Pharma Limited |
0.99 |
| ACUTAAS CHEMICALS LIMITED |
0.95 |
| Abbott India Limited |
0.92 |
| Neuland Laboratories Limited |
0.92 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
